Create Free Account

By creating account you will get access to hot stocks & personalised emails

Epsilon Healthcare Ltd

Healthcare AU EPN

0.024AUD
-(-%)

Last update at 2025-01-19T23:00:00Z

Day Range

0.020.02
LowHigh

52 Week Range

0.020.02
LowHigh

Fundamentals

  • Previous Close 0.02
  • Market Cap7.21M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.62856M
  • Revenue TTM7.21M
  • Revenue Per Share TTM0.03
  • Gross Profit TTM 1.24M
  • Diluted EPS TTM-0.01

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -12.67747M -10.36582M -10.94766M -11.67918M -8.61127M
Minority interest - - - - -
Net income -12.67747M -8.90840M -10.94766M -11.67918M -8.61127M
Selling general administrative 3.91M 6.85M 6.95M 5.14M 4.86M
Selling and marketing expenses 0.34M 0.42M 0.84M 0.67M 0.40M
Gross profit 1.34M 2.06M 2.66M 1.14M 0.76M
Reconciled depreciation 1.86M 1.56M 1.57M 0.22M 0.12M
Ebit -9.54580M -7.05131M -10.34992M -8.99831M -7.32722M
Ebitda -7.69029M -5.49339M -8.77972M -8.77621M -7.21208M
Depreciation and amortization 1.86M 1.56M 1.57M 0.22M 0.12M
Non operating income net other - - - - -
Operating income -9.54580M -7.05131M -10.34992M -8.99831M -7.32722M
Other operating expenses 16.80M 15.00M 18.15M 14.04M 10.25M
Interest expense 0.58M 0.80M 0.60M 0.14M 0.08M
Tax provision 0.00000M -1.45742M 0.00000M 0.00000M 0.00000M
Interest income 0.60M 0.83M 0.60M 0.18M 0.08M
Net interest income -0.67763M -0.79939M -0.59774M -0.14370M -0.08405M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.82M -1.45742M 1.03M 0.40M 0.34M
Total revenue 7.11M 5.50M 7.36M 4.79M 2.66M
Total operating expenses 11.03M 11.56M 13.45M 10.39M 8.34M
Cost of revenue 5.78M 3.44M 4.70M 3.65M 1.90M
Total other income expense net -2.30999M -0.06704M 0.44M -2.28523M -0.94536M
Discontinued operations - - - - -
Net income from continuing ops -12.67747M -8.90840M -10.94766M -11.70351M -8.61127M
Net income applicable to common shares -13.28856M -9.24318M -10.53505M -11.70351M -8.61127M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 20.50M 30.55M 37.26M 27.81M 32.75M
Intangible assets 0.00000M 0.50M 0.48M 0.00000M 1.05M
Earning assets - - - - -
Other current assets 0.76M 0.71M 0.41M -0.02433M -
Total liab 11.23M 10.98M 11.94M 5.49M 4.66M
Total stockholder equity 9.27M 19.57M 25.32M 22.32M 28.09M
Deferred long term liab - - - - -
Other current liab 0.74M 1.09M 0.95M - 0.03M
Common stock 46.88M 44.82M 42.85M 28.45M 25.68M
Capital stock 46.88M 44.82M 41.80M 28.45M 23.00M
Retained earnings -48.97157M -35.96932M -28.98033M -17.17062M -10.99848M
Other liab 2.65M 3.19M 3.89M 3.89M 3.89M
Good will 0.00000M 4.47M 5.45M 2.42M 3.32M
Other assets 0.12M 0.13M 0.26M 0.25M 1.76M
Cash 0.86M 2.34M 6.97M 3.55M 6.33M
Cash and equivalents - - - 3.55M 6.33M
Total current liabilities 7.93M 7.14M 7.08M 0.89M 0.36M
Current deferred revenue 0.64M 0.93M 0.56M - -
Net debt 2.34M 1.99M -1.85584M -2.84033M -5.92542M
Short term debt 2.54M 3.67M 3.79M 0.00000M 0.00000M
Short long term debt 2.55M 3.55M 3.79M - -
Short long term debt total 3.20M 4.33M 5.11M 0.71M 0.41M
Other stockholder equity -0.61109M -0.74895M -0.19098M -0.02433M -0.03000M
Property plant equipment 15.62M 17.48M 19.87M 18.76M 17.80M
Total current assets 4.76M 7.81M 11.01M 6.13M 8.51M
Long term investments - 0.13M 0.26M - -
Net tangible assets 9.88M 14.44M 19.19M 19.65M 23.41M
Short term investments - - - - -
Net receivables 3.15M 2.16M 1.53M 1.26M 0.87M
Long term debt - - - - -
Inventory 0.61M 2.42M 2.09M 1.35M 1.31M
Accounts payable 4.65M 2.38M 2.34M 0.89M 0.33M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 11.98M 11.47M 11.64M 11.07M 13.43M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.12M 0.13M 0.00653M 0.25M 1.76M
Deferred long term asset charges - - - - -
Non current assets total 15.74M 22.74M 26.26M 21.68M 24.24M
Capital lease obligations 0.65M 0.78M 1.32M 0.71M 0.41M
Long term debt total 0.65M 0.66M 1.32M 0.71M 0.41M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.52940M -0.73759M -1.73230M -0.71468M -3.05854M
Change to liabilities 0.00000M 0.31M 1.34M 0.53M -0.24398M
Total cashflows from investing activities -0.52940M -0.73759M -1.73156M -0.71468M -3.05854M
Net borrowings -1.28191M -0.92974M 3.20M 1.16M 1.16M
Total cash from financing activities 1.61M 1.47M 14.60M 5.78M 4.20M
Change to operating activities - - - - -
Net income -12.67747M -9.24318M -10.53505M -11.70351M -8.61127M
Change in cash -1.47358M -4.63237M 3.42M -2.78194M -4.70415M
Begin period cash flow 2.34M 6.97M 3.55M 6.33M 11.04M
End period cash flow 0.86M 2.34M 6.97M 3.55M 6.33M
Total cash from operating activities -2.57065M -5.42942M -8.69378M -7.75977M -5.85011M
Issuance of capital stock - 2.45M 10.64M 4.52M 4.20M
Depreciation 1.86M 1.09M 1.51M 0.17M 0.08M
Other cashflows from investing activities 0.00000M 0.01M -0.49655M 0.00000M -0.02717M
Dividends paid - - - - -
Change to inventory - -0.45661M -0.38614M -0.00626M -0.15310M
Change to account receivables - -0.84375M -1.07724M -0.66890M -0.16949M
Sale purchase of stock 2.89M 2.51M 10.84M 4.52M 4.20M
Other cashflows from financing activities -0.52940M -0.56470M 3.76M 1.26M -3.05854M
Change to netincome 8.24M 3.66M 0.40M 3.87M 3.21M
Capital expenditures 0.53M 0.75M 1.24M 0.71M 3.03M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 1.11M 1.04M 0.43M 0.30M 0.13M
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow -0.52940M -0.74771M -1.23575M -0.71468M -3.03138M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EPN
Epsilon Healthcare Ltd		 - -% 0.02 - - 1.00 0.79 1.34 -3.0188
AFP
AFT Pharmaceuticals Ltd		 - -% 2.54 26.10 13.11 1.41 3.61 1.66 14.38
LV1
Live Verdure Ltd		 0.06 6.78% 0.94 - - 72.97 55.31 74.79 -5.083
SNT
Syntara Limited		 0.002 2.74% 0.07 - 20.45 20.00 24.29 6.32 -2.1607
VLS
Vita Life Sciences Ltd		 - -% 2.00 11.71 - 1.40 2.27 1.06 6.10

Reports Covered

Stock Research & News

View All

Profile

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia.

Epsilon Healthcare Ltd

9 Castlereagh Street, Sydney, NSW, Australia, 2000

Key Executives

Name Title Year Born
Mr. Sonny Didugu Group COO & Joint Company Sec. NA
Ms. Laura Harvey Chief Operations Officer - Canada NA
Ms. Diandra Phipps Chief Operating Officer of Tetra Health NA
Mr. Mark Audet CFO & Joint Company Sec. NA
Mr. Jim Barlow Chief Agronomist and Regional Mang. of the Americas NA
Mr. Xiao Cui Executive Chairman NA
Mr. Daniel Sanghera Interim Chief Executive Officer NA
Ms. Li Lin Group Financial Controller NA
Mr. Marcelo Mora Company Secretary NA
Mr. Xiao Cui Executive Chairman NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2025 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.